Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders

 
 

NOVELION THERAPEUTICS INC. (NVLNF) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $0.71 Metrics
OS: 19.0 M
Market cap: $13.5 M -67 % ROIC
Net debt: $359 M
EV: $373 M

 
TTM Valuation
EBITDA ($15.7) M
EBIT ($42.4) M
EPS ($5.69)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12Dec-31-11
Revenues130.4138.413.60.00.00.00.00.0
            Revenue growth-5.8%919.9%      
Cost of goods sold59.777.26.0-26.0-32.20.00.00.0
Gross profit70.761.27.626.032.20.00.00.0
            Gross margin54.2%44.2%56.0%     
Selling, general and administrative79.896.529.516.217.77.015.117.1
Research and development38.849.014.89.813.818.524.623.0
EBITA-22.8-59.2-25.9-23.3-5.1-26.5-40.8-41.4
            EBITA margin-17.5%-42.8%-190.6%     
Amortization of intangibles25.125.12.1     
EBIT-47.9-84.3-28.0-23.3-5.1-26.5-40.8-41.4
            EBIT margin-36.7%-60.9%-206.3%     
Pre-tax income-106.7-126.1-52.4-23.0-4.2-25.2-46.2-30.2
Income taxes-1.60.60.50.0-0.20.6-3.91.2
            Tax rate1.5%   4.6% 8.4% 
Earnings from continuing ops-108.3-126.7-52.9-23.0-3.9-25.8-42.3-31.4
Earnings from discontinued ops    -0.1  1.0
Net income-108.3-126.7-52.9-23.0-4.0-25.845.7-30.4
            Net margin-83.0%-91.5%-389.5%     
 
Diluted EPS($5.76)($6.81)($4.69)($2.21)($0.39)($0.51)($0.84)($0.63)
Shares outstanding (diluted)18.818.611.310.410.250.950.150.1
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy